Filing Details

Accession Number:
0001181431-11-018577
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-17 08:15:04
Reporting Period:
2011-03-15
Filing Date:
2011-03-17
Accepted Time:
2011-03-17 08:15:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131907 Micromet Inc. MITI Biological Products, (No Disgnostic Substances) (2836) 522243564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413481 L Mark Reisenauer 6707 Democracy Blvd
Bethesda MD 20817
Svp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-03-15 111,100 $1.98 111,100 No 4 M Direct
Common Stock Disposition 2011-03-15 111,100 $5.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-03-15 90,909 $0.00 90,909 $1.98
Common Stock Stock Option (right to buy) Disposition 2011-03-15 20,191 $0.00 20,191 $1.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,354 2011-03-01 2017-10-01 No 4 M Direct
28,547 2010-12-01 2017-10-01 No 4 M Direct
Footnotes
  1. Price reflected is the weighed-average sale price for shares sold. The range of sale prices for the transactions reported was $5.10 to $5.1274 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Twenty-five percent of the shares underlying this option vested on October 1, 2008, with the remainder vesting in equal monthly installments through October 1, 2011.